CD274 and neoplasm: On the surface of tumors, PD-L1 engages with PD-1 on immune cells, primarily suppressing the effector functions of cytotoxic T lymphocytes, thereby facilitating Tumor growth and immune evasion (34). A high expression of PD-L1 is notably correlated with better clinical outcomes in patients receiving PD-L1 directed treatment (35).